Menu
Lilly is a global health care leader that unites caring with discovery to create medicines that make life better for people around the world. It was founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today it remains true to that mission in all its work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Lilly Corporate Ctr
Indianapolis, Indiana 46285-0001
Phone: 13172762000
www.lilly.com
Eli Lilly (LLY) appoints Patrik Jonsson as head of its diabetes and obesity division in place of Mike Mason who is set to retire at the year-end. Read more here.
https://www.investing.com/news/stock-market-news/eli-lilly-diabetes--obesity-president-to-retire-shares-dip-432SI-3190128
https://www.investing.com/news/stock-market-news/eli-lillys-head-of-diabetes-and-obesity-unit-to-retire-3190107
#Eli #Lilly #buys #Point #Biopharma #radiopharmaceuticals #play Pharmaceutical company Eli Lilly is acquiring Point Biopharma for $1.4 billion, a 90% premium. Point Biopharma focuses on the development of cancer drugs that deliver radiation to tumor cells. Data for its lead medicine, targeting prostate cancer, is expected in Q4. The company is also working on a …
Receive free Eli Lilly & Co updates We’ll send you a myFT Daily Digest email rounding up the latest Eli Lilly & Co news every morning. Eli Lilly, the world’s largest drugmaker, plans to bolster its portfolio of cancer drugs by buying Point Biopharma for $1.4bn, paying a premium of almost 90 per cent to … The post Eli Lilly to buy cancer specialist Point for $1.4bn appeared first on Best News .
U.S. stocks extended losses toward the end of trading, with the S&P 500 falling around 1.5% on Tuesday. The Dow traded down 1.43% to 32,954.84 while the NASDAQ fell 1.98% to 13,044.24. The S&P 500 also fell, dropping, 1.53% to 4,222.58. Check This Out: Vivani Medical And 3 Other Stocks Under $2 Insiders Are Buying Leading and Lagging Sectors Utilities shares rose by 0.6% on Tuesday. In trading on Tuesday, consumer discretionary shares dipped by around 2.4%. Top Headline The number of job openings increased by 690,000 from the prior month to 9.61 million in August, compared to market estimates of 8.8 million. Equities Trading UP Vericity, Inc. (NASDAQ: VERY ) shares shot up 86% to $11.02 after iA Financial Group announced it will acquire the company. Shares of POINT Biopharma Global Inc. (NASDAQ: PNT ) got a boost, shooting 85% to $12.40. Eli Lilly And Co (NYSE: LLY ) agreed to acquire POINT Biopharma Global at $12.50 per share in cash, an aggregate of approximately $1.4 billion. ALX Oncology Holdings Inc. (NASDAQ: ALXO ) shares were also up, gaining 50% to $7.22 after the company released interim Phase 2 data …
The company entered into a buyout agreement with Eli Lilly.
Gainers Vericity, Inc. (NASDAQ: VERY ) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. POINT Biopharma Global Inc. (NASDAQ: PNT ) surged 84.7% to $12.35. Eli Lilly And Co (NYSE: LLY ) agreed to acquire POINT Biopharma Global at $12.50 per share in cash, an aggregate of approximately $1.4 billion. ALX Oncology Holdings Inc. (NASDAQ: ALXO ) shares jumped 56% to $7.50 after the company released interim Phase 2 data from its ASPEN-06 trial of evorpacept in advanced HER2-positive gastric cancer. SeaStar Medical Holding Corporation (NASDAQ: ICU ) gained 53.3% to $0.6398 after jumping 58% on Monday. SeaStar Medical was recently granted Breakthrough Device Designation by the FDA for its Selective Cytopheretic Device for Cardiorenal Syndrome. VIQ Solutions Inc. (NASDAQ: VQS ) shares jumped 52% to $0.1991 after falling 18% on Monday. VIQ Solutions recently announced delisting from the Nasdaq. SciSparc Ltd. (NASDAQ: SPRC ) shares gained 48.3% to $5.46 after the company announced it was granted a European patent for its core technology.
